Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

OB:AKRBP
OB:AKRBPOil and Gas

A Look At Aker BP (OB:AKRBP) Valuation After Early Symra Field Production Start

Aker BP (OB:AKRBP) has begun oil production at the Symra field in the North Sea, nine months ahead of plan. This brings forward expected value creation and adds an estimated 63 million barrels of oil equivalent. See our latest analysis for Aker BP. The Symra start up comes as Aker BP’s share price has gained 29% over the past 90 days and delivered a 75.6% total shareholder return over one year, suggesting momentum has been building alongside operational progress. If you are assessing oil...
NasdaqGS:OZK
NasdaqGS:OZKBanks

A Look At Bank OZK (OZK) Valuation After Its Latest Dividend Increases And Ongoing Earnings Caution

Dividend actions put Bank OZK (OZK) back in focus Bank OZK (OZK) has drawn fresh attention after its Board approved the 63rd consecutive quarterly dividend raise on common stock and declared a new preferred stock dividend, reflecting a consistent approach to returning cash to shareholders. See our latest analysis for Bank OZK. At a share price of US$47.94, Bank OZK has a 1 month share price return of 10.46% and a 1 year total shareholder return of 31.22%. This suggests momentum has...
NYSE:RNST
NYSE:RNSTBanks

Renasant (RNST) Valuation Check After Recent Share Price Strength And Merger Growth Story

Renasant stock snapshot after recent performance shift Renasant (RNST) has drawn fresh attention after a recent shift in its share performance, with the stock showing mixed short term moves but double digit gains over the past month and past 3 months. See our latest analysis for Renasant. At the current share price of $39.40, Renasant has seen a 1 day share price return of 0.86% decline, while its recent 30 day share price return of 10.49% and 1 year total shareholder return of 45.91% reflect...
TSE:6278
TSE:6278Machinery

A Look At Union Tool’s Valuation As The Board Weighs Treasury Stock Disposal And A Secondary Offering

Why the upcoming board meeting matters for shareholders Union Tool (TSE:6278) has scheduled an April 6, 2026 board meeting to consider disposing of treasury stock and a secondary share offering. These decisions could reshape its capital structure and future share supply. See our latest analysis for Union Tool. Union Tool's share price has shown strong momentum recently, with a 17.25% 7 day share price return and 85.16% 90 day share price return, while the 1 year total shareholder return is...
NYSE:AMG
NYSE:AMGCapital Markets

A Look At Affiliated Managers Group’s Valuation As 2025 Investments Signal Confidence In Alternatives Growth

Affiliated Managers Group (AMG) highlighted 2025 as one of its strongest years, pointing to over US$1b committed to alternative strategies, new U.S. wealth market collaborations, sizable share repurchases, and capital structure refinancing as key developments. See our latest analysis for Affiliated Managers Group. The recent commitments to alternative strategies and U.S. wealth partnerships come as the share price trades at US$285.36, with a 7.5% 7 day share price return but a 90 day share...
SEHK:136
SEHK:136Entertainment

China Ruyi Holdings (SEHK:136) Valuation Check After Full Year 2025 Earnings Turnaround

Why China Ruyi’s Earnings Turnaround Matters China Ruyi Holdings (SEHK:136) reported a full year earnings turnaround for 2025, shifting from a net loss to a net profit of CN¥1,796.64 million, which is drawing fresh attention to the stock. Sales for the year came in at CN¥3,342.98 million. Basic and diluted earnings per share from continuing operations were CN¥11.42, compared with a basic and diluted loss per share of CN¥1.57 a year earlier. See our latest analysis for China Ruyi Holdings. The...
NYSE:TEX
NYSE:TEXMachinery

Is It Too Late To Consider Terex (TEX) After Its 83% One Year Share Price Surge?

Wondering whether Terex is still priced sensibly after a strong run, or if the current share price is getting ahead of itself, starts with understanding what the market is actually paying for its fundamentals. Over the past year Terex has recorded an 83.2% return, with gains of 8.0% over 7 days, 6.3% over 30 days and 14.8% year to date, which has naturally sharpened questions around both upside potential and risk. Recent coverage has focused on Terex's position within the capital goods...
NYSE:TKO
NYSE:TKOEntertainment

Expanded FRE Sponsorship Across Combat Sports Might Change The Case For Investing In TKO Group Holdings (TKO)

TKO Group Holdings recently announced a comprehensive multiyear partnership with FRE Nicotine Pouches, making FRE the Official Nicotine Pouch Partner across six TKO-affiliated sports properties including UFC, Zuffa Boxing, PBR, UFC BJJ, World’s Strongest Man and Formula Drift, with activations beginning at UFC 327 in Miami. The deal underscores how TKO is expanding high-margin sponsorship categories by aligning brands with its adult-skewing combat sports audiences across multiple...
NasdaqGS:ZS
NasdaqGS:ZSSoftware

Zscaler (ZS) Is Down 14.8% After BTIG Downgrade On Intensifying Zero Trust Competition

Earlier this week, Zscaler reported quarterly results with revenue growth beating analyst expectations and raised earnings guidance, while CEO Jay Chaudhry emphasized the company’s role in securing AI-era workflows on its Zero Trust platform. Soon after, BTIG downgraded Zscaler to Neutral amid concerns about rising competition from Cloudflare, Netskope and enhanced SASE offerings from firewall vendors, highlighting a tension between strong current performance and a tougher market...
SWX:AVOL
SWX:AVOLSpecialty Retail

A Look At Avolta (SWX:AVOL) Valuation After New 15 Year Jacksonville Airport Contract

Avolta (SWX:AVOL) has secured a 15 year food and beverage contract at Jacksonville International Airport in Florida, adding a new airport food hall with four outlets that mix local concepts and national brands. See our latest analysis for Avolta. The Jacksonville contract lands at a time when Avolta’s share price sits at CHF52.2, with a 1 month share price return of 8.70% and a 1 year total shareholder return of 57.10%. This suggests momentum has been building recently despite a weaker 5 year...
NYSE:NBHC
NYSE:NBHCBanks

Do NBHC’s Earnings Miss Reshape the Case for Its Vista Integration and 2UniFi Strategy?

In the past quarter, National Bank Holdings reported revenues of US$103.3 million, a 3.6% decline year on year and below analysts’ expectations, with net interest income and EPS also missing consensus estimates. Despite this weaker financial performance, the bank remains in focus as it integrates Vista Bancshares and continues rolling out its 2UniFi digital platform, developments that could influence how investors interpret the latest results. Now we’ll examine how the disappointing earnings...
TSE:7936
TSE:7936Luxury

Assessing ASICS (TSE:7936) Valuation After Strong Recent Share Price Gains

Recent share performance and what it may signal ASICS (TSE:7936) has drawn investor attention after a recent 3.6% one day move, adding to gains of about 6% over the past week and 10% over the past 3 months. Over the past year, the stock shows a total return of about 57%, with year to date performance near 19%. These moves come alongside reported annual revenue of ¥810,916 and net income of ¥98,719. See our latest analysis for ASICS. The recent 1 day share price return of 3.6% and 7 day share...
NasdaqGS:ZION
NasdaqGS:ZIONBanks

Assessing Zions Bancorporation (ZION) Valuation After A Strong Year Of Shareholder Returns

Zions Bancorporation National Association (ZION) has drawn fresh attention after its recent share price move, with the stock showing mixed short term performance but significantly different returns over the past year. See our latest analysis for Zions Bancorporation National Association. The latest move to US$61.05 comes after a 15% 30 day share price return and a 50% 1 year total shareholder return. This suggests momentum has been building despite some recent day to day volatility. If Zions'...
XTRA:AFX
XTRA:AFXMedical Equipment

Assessing Carl Zeiss Meditec (XTRA:AFX) Valuation After The ZEISS Crossbeam 750 FIB SEM Launch

ZEISS parent Carl Zeiss Meditec (XTRA:AFX) has drawn fresh attention after unveiling the ZEISS Crossbeam 750 FIB SEM, a high precision system aimed at semiconductor, nanofabrication, and materials science workflows. See our latest analysis for Carl Zeiss Meditec. While the ZEISS Crossbeam 750 launch has coincided with a 9.82% 1 month share price return and a 4.43% 7 day share price return, the 1 year total shareholder return of 50.70% and 5 year total shareholder return of 81.22% suggest that...
NasdaqGS:EVRG
NasdaqGS:EVRGElectric Utilities

Does BTIG’s Bullish View Reframe Evergy’s Regulated Growth Narrative and Valuation Risk Balance (EVRG)?

Earlier this week, BTIG Research initiated analyst coverage on Evergy with a Buy rating, citing substantial earnings growth potential and a supportive regulatory backdrop in its Midwestern service territories. The coverage highlights how Evergy’s earnings profile could eventually warrant a premium valuation within the utility sector if its growth plans materialize as expected. We’ll now examine how BTIG’s emphasis on Evergy’s earnings growth prospects interacts with the existing investment...
NYSE:EMR
NYSE:EMRElectrical

A Look At Emerson Electric (EMR) Valuation As Earnings Beat And Guidance Upgrade Lift Interest

Emerson Electric (EMR) has been in focus after quarterly results topped expectations and management raised full year guidance, with major analysts maintaining positive ratings as industrial equipment and automation stocks continued to attract interest. See our latest analysis for Emerson Electric. The strong earnings surprise and guidance upgrade helped spark a sharp rally. At a share price of US$143.77, the stock now sits on a 7 day share price return of 9.16% and a 1 year total shareholder...
NYSE:CRBG
NYSE:CRBGDiversified Financial

Do Reaffirmed Analyst “Overweight” Calls on Corebridge (CRBG) Mask Shifting Views on Its Risk Profile?

In recent days, multiple research firms including Keefe, Bruyette & Woods, Barclays and Wells Fargo have updated their views on Corebridge Financial, largely reaffirming positive ratings such as “Outperform” and “Overweight” while revising their assessments of the company’s outlook. This cluster of analyst actions highlights sustained institutional interest in Corebridge’s business model and market position, even as opinions on its prospects are being recalibrated. Next, we’ll examine how...
XTRA:P911
XTRA:P911Auto

Porsche Delivery Slump Tests EV Pivot And New CEO Reset

Porsche, ticker XTRA:P911, reported a sharp global drop in vehicle deliveries in the first quarter. Weakness was most evident in China and the US, where the loss of electric vehicle tax incentives weighed on demand. The company has discontinued several combustion engine models and is reallocating resources toward the all electric Cayenne. A new CEO is leading a cost cutting program alongside the product shift. Porsche shares last closed at €40.93, with a 3.5% gain over the past week and...
NYSE:BKE
NYSE:BKESpecialty Retail

Assessing Buckle (BKE) Valuation After Recent Sales Momentum And Leadership Appointment

Sales update and leadership change draw attention to Buckle (BKE) Buckle (BKE) has drawn fresh investor attention after reporting higher comparable store and total net sales for recent 5 week and 9 week periods, alongside appointing longtime executive Scott A. Werth as Senior Vice President of Stores. See our latest analysis for Buckle. Buckle’s recent sales update and leadership change arrived after a mixed share price pattern, with a 9.4% 7 day share price return and a 71.3% 1 year total...
NasdaqGS:UTHR
NasdaqGS:UTHRBiotechs

A Look At United Therapeutics (UTHR) Valuation After RMAT Win And Tyvaso Phase 3 Success

United Therapeutics (UTHR) stock is in focus after two pipeline milestones: FDA RMAT designation for the investigational miroliverELAP liver support device and positive phase 3 data for nebulized Tyvaso in idiopathic pulmonary fibrosis. See our latest analysis for United Therapeutics. The recent RMAT designation for miroliverELAP and phase 3 Tyvaso IPF data arrive after a strong run, with an 18.5% 90 day share price return and a 103.4% 1 year total shareholder return, suggesting that momentum...
NasdaqGS:EXPE
NasdaqGS:EXPEHospitality

How Investors Are Reacting To Expedia Group (EXPE) Billion-Dollar Note Sale And New Credit Facility

Expedia Group has recently completed a US$1.00 billion offering of 5.500% senior unsecured notes due 2036 at a slight discount to par, alongside securing a new US$2.50 billion unsecured revolving credit facility maturing in 2031. The combination of fresh bond proceeds, flexible undrawn credit capacity, and investment-grade ratings underscores Expedia’s emphasis on funding optionality for debt repayment, buybacks, and ongoing operations. Next, we’ll examine how this sizeable senior notes...